GI
TAK icon

GAMMA Investing’s Takeda Pharmaceutical TAK Stock Holding History

GAMMA Investing’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$222K Buy
13,837
+1,338
+11% +$22.1K 0.01% 1196
2026
Q1 		$231K Buy
12,499
+3,361
+37% +$59K 0.01% 1010
2025
Q4 		$142K Sell
9,138
-68
-0.7% -$972 0.01% 1301
2025
Q3 		$135K Buy
9,206
+152
+2% +$2.26K 0.01% 1259
2025
Q2 		$140K Buy
9,054
+2,012
+29% +$29.7K 0.01% 1171
2025
Q1 		$105K Buy
7,042
+1,296
+23% +$18.2K 0.01% 1215
2024
Q4 		$76.1K Sell
5,746
-549
-9% -$7.54K 0.01% 1320
2024
Q3 		$89.5K Buy
6,295
+3,629
+136% +$51.5K 0.01% 1073
2024
Q2 		$34.5K Sell
2,666
-198
-7% -$2.62K ﹤0.01% 1464
2024
Q1 		$39.8K Buy
2,864
+966
+51% +$14K 0.01% 1189
2023
Q4 		$27.7K Buy
+1,898
New +$26.9K 0.01% 1271

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

GAMMA Investing's TAK Position: Q2 2026 in Review

GAMMA Investing increased its Takeda Pharmaceutical (TAK) stake by 11% in Q2 2026, buying an estimated $22.1K and bringing the position to 13,837 shares worth $222K. The position accounts for 0.01% of the portfolio, ranked #1196.

GAMMA Investing first reported a position in TAK in Q4 2023 and has held it in 11 quarters since. The position peaked at $231K in Q1 2026. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • GAMMA Investing held 13,837 shares of Takeda Pharmaceutical worth $222K as of Q2 2026.
  • GAMMA Investing bought 1,338 Takeda Pharmaceutical shares in Q2 2026, an estimated $22.1K.
  • Takeda Pharmaceutical made up 0.01% of GAMMA Investing's portfolio in Q2 2026, its #1196 holding.
  • GAMMA Investing first reported a position in Takeda Pharmaceutical in Q4 2023 and has held it in 11 quarters since.
  • GAMMA Investing's Takeda Pharmaceutical position peaked at $231K in Q1 2026.
  • 376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.